Please assess the completion status of the following clinical trial:

Trial Title: Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women without menstrual cycles within the last 12 months and FSH \> 30IU/L~* Healthy women~* Women that were not using drugs with potential vascular effect within the last 1 year~* Women that never used hormone replacement therapy~Exclusion Criteria:~* Smoking~* Blood Pressure \> 160/90 mm Hg.~* Breast and or endometrial cancer~* History of acute myocardial infarction~* Diabetes~* Vaginal bleeding of any origin~* Hepatic disease~* Thrombophlebitis or thromboembolic disorders

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Estrogen use (Type: EXPERIMENTAL): climacteric women will use conjugated equine estrogens
- use of Placebo (Type: PLACEBO_COMPARATOR): climacteric women will use placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).